155 related articles for article (PubMed ID: 37336810)
1. The RNA-Binding Proteins OAS1, ZFP36L2, and DHX58 Are Involved in the Regulation of CD44 mRNA Splicing in Colorectal Cancer Cells.
Novosad VO; Maltseva DV
Bull Exp Biol Med; 2023 May; 175(1):144-149. PubMed ID: 37336810
[TBL] [Abstract][Full Text] [Related]
2. Identification of Significant RNA-Binding Proteins in the Process of CD44 Splicing Using the Boosted Beta Regression Algorithm.
Novosad VO
Dokl Biochem Biophys; 2023 Jun; 510(1):99-103. PubMed ID: 37582871
[TBL] [Abstract][Full Text] [Related]
3. The p53-induced RNA-binding protein ZMAT3 is a splicing regulator that inhibits the splicing of oncogenic CD44 variants in colorectal carcinoma.
Muys BR; Anastasakis DG; Claypool D; Pongor L; Li XL; Grammatikakis I; Liu M; Wang X; Prasanth KV; Aladjem MI; Lal A; Hafner M
Genes Dev; 2021 Jan; 35(1-2):102-116. PubMed ID: 33334821
[TBL] [Abstract][Full Text] [Related]
4. Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72.
Hönig A; Auboeuf D; Parker MM; O'Malley BW; Berget SM
Mol Cell Biol; 2002 Aug; 22(16):5698-707. PubMed ID: 12138182
[TBL] [Abstract][Full Text] [Related]
5. The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44.
David G; Reboutier D; Deschamps S; Méreau A; Taylor W; Padilla-Parra S; Tramier M; Audic Y; Paillard L
Biochem Biophys Res Commun; 2022 Oct; 626():79-84. PubMed ID: 35973378
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.
Kjær KH; Pahus J; Hansen MF; Poulsen JB; Christensen EI; Justesen J; Martensen PM
BMC Cell Biol; 2014 Sep; 15():33. PubMed ID: 25205466
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD44 Isoforms in Tumor Samples and Cell Lines of Human Colorectal Cancer.
Novosad VO; Polikanova IS; Tonevitsky EA; Maltseva DV
Bull Exp Biol Med; 2022 May; 173(1):155-159. PubMed ID: 35618971
[TBL] [Abstract][Full Text] [Related]
8. SR protein expression and CD44 splicing pattern in human breast tumours.
Pind MT; Watson PH
Breast Cancer Res Treat; 2003 May; 79(1):75-82. PubMed ID: 12779084
[TBL] [Abstract][Full Text] [Related]
9. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
Elife; 2018 Jul; 7():. PubMed ID: 30059005
[TBL] [Abstract][Full Text] [Related]
10. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
11. SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer.
Matsumoto Y; Itou J; Sato F; Toi M
Cancer Med; 2018 Feb; 7(2):454-462. PubMed ID: 29356399
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Human OAS1 Isoform Proteins.
Di H; Elbahesh H; Brinton MA
Viruses; 2020 Jan; 12(2):. PubMed ID: 32013110
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
Roy Burman D; Das S; Das C; Bhattacharya R
Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
[TBL] [Abstract][Full Text] [Related]
14. mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients.
Latini A; Novelli L; Ceccarelli F; Barbati C; Perricone C; De Benedittis G; Conti F; Novelli G; Ciccacci C; Borgiani P
Lupus; 2021 Jun; 30(7):1086-1093. PubMed ID: 33794704
[TBL] [Abstract][Full Text] [Related]
15. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress-induced alternative splicing of transformer 2beta (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells.
Takeo K; Kawai T; Nishida K; Masuda K; Teshima-Kondo S; Tanahashi T; Rokutan K
Am J Physiol Cell Physiol; 2009 Aug; 297(2):C330-8. PubMed ID: 19439532
[TBL] [Abstract][Full Text] [Related]
17. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.
Warzecha CC; Sato TK; Nabet B; Hogenesch JB; Carstens RP
Mol Cell; 2009 Mar; 33(5):591-601. PubMed ID: 19285943
[TBL] [Abstract][Full Text] [Related]
18. Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion.
Gaiteiro C; Soares J; Relvas-Santos M; Peixoto A; Ferreira D; Paulo P; Brandão A; Fernandes E; Azevedo R; Palmeira C; Freitas R; Miranda A; Osório H; Prieto J; Lima L; Silva AMN; Santos LL; Ferreira JA
Theranostics; 2022; 12(7):3150-3177. PubMed ID: 35547758
[No Abstract] [Full Text] [Related]
19. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x.
Paronetto MP; Achsel T; Massiello A; Chalfant CE; Sette C
J Cell Biol; 2007 Mar; 176(7):929-39. PubMed ID: 17371836
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
